Efficient One-Pot Synthesis
of 2-Substituted Benzimidazoles from Triacyloxyborane
Intermediates

Wenge Cui; Robert B. Kargbo; Zohreh Sajjadi-Hashemi; Feryan Ahmed; Jolicia F. Gauuan

doi:10.1055/s-0031-1290129

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2012(2): 247-250
DOI: 10.1055/s-0031-1290129

LETTER

Efficient One-Pot Synthesis of 2-Substituted Benzimidazoles from Triacyloxyborane Intermediates

Wenge Cui*, Robert B. Kargbo, Zohreh Sajjadi-Hashemi, Feryan Ahmed, Jolicia F. Gauuan
Department of Medicinal Chemistry, AMRI, 26 Corporate Circle, Albany, NY 12212-5098, USA
Fax: +1(518)5122079; e-Mail: wenge.cui@amriglobal.com;

Further Information

Publication History

Received 11 October 2011
Publication Date:
03 January 2012 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

An efficient one-pot synthesis of 2-substituted benzimidazoles via triacyloxyborane intermediates is reported. The mild protocol is efficient and tolerant of acid-labile functional groups.

Key words

benzimidazoles - borane-THF - carboxylic acids - triacyloxyboranes - diacyloxyboric acids - benzoxazoles

References and Notes

1a Fellenius E. Berglindh T. Sachs G. Olbe L. Elander B. Sjostrand SE. Wallmark B. Nature (London) 1981, 290: 159

Google Scholar
1b Yamada M. Yura T. Morimoto M. Harada T. Yamada K. Honma Y. Kinoshita M. Sugiura M.
J. Med. Chem. 1996, 39: 596

Google Scholar
2a Eriksson BI. Smith H. Yasothan U. Kirkpatrick P. Nat. Rev. Drug Discovery 2008, 7: 557

Google Scholar
2b Hauel NH. Nar H. Priepke H. Ries U. Stassen J. Wienen W.
J. Med. Chem. 2002, 45: 1757

Google Scholar
2c Ueno H. Katoh S. Yokota K. Hoshi J.-i. Hayashi M. Uchida I. Aisaka K. Hase Y. Cho H. Bioorg. Med. Chem. Lett. 2004, 14: 4281

Google Scholar
3 Mizuno CS. Chittiboyina AG. Shah FH. Patny A. Kurtz TW. Pershadsingh HA. Speth RC. Karamyan VT. Carvalho PB. Avery MA. J. Med. Chem. 2010, 53: 1076

Google Scholar
4a Spasov AA. Yozhitsa IN. Bugaeva LI. Anisimova VA. Pharm. Chem. J. 1999, 33: 232

Google Scholar
4b Beaulieu PL. Bousquet Y. Gauthier J. Gillard J. Marquis M. McKercher G. Pellerin C. Valois S. Kukolj G. J. Med. Chem. 2004, 47: 6884

Google Scholar
4c Roth T. Morningstar ML. Boyer PL. Hughes SH. Buckheit RW. Michejda CJ. J. Med. Chem. 1997, 40: 4199

Google Scholar
5a Mann J. Baron A. Opoku-Boahen Y. Johansson E. Parkinson G. Kelland LR. Neidle S. J. Med. Chem. 2001, 44: 138

Google Scholar
5b Soderlind K.-J. Gorodetsky B. Singh AK. Bachur NR. Miller GG. Lown JW. Anti-Cancer Drug Des. 1999, 14: 19

Google Scholar
5c Kim JS. Gatto B. Yu C. Liu A. Liu LF. LaVoie EJ. J. Med. Chem. 1996, 39: 992

Google Scholar
5d Chen AY. Yu C. Gatto B. Liu LF. Proc. Natl. Acad. Sci. U.S.A. 1993, 90: 8131

Google Scholar
6 Janssens F. Torremans J. Janssen M. Stokbroekx RA. Luyckx M. Janssen PAJ. J. Med. Chem. 1985, 28: 1925

Google Scholar
7 Schwartz G. Fehse K. Pfeiffer M. Walzer K. Leo K. Appl. Phys. Lett. 2006, 89: 83509

Google Scholar
8a Asensio JA. Gomez-Romero P. Fuel Cells 2005, 5

Google Scholar
8b Weber J. Antonietti M. Thomas A. Macromolecules 2007, 40: 1299

Google Scholar
For comprehensive reviews on the chemistry of benz-imidazoles, see:
9a Wright JB. Chem. Rev. 1951, 48: 397

Google Scholar
9b Preston PN. Chem. Rev. 1974, 74: 279

Google Scholar
9c Grimmett MR. Imidazoles and their Benzo Derivatives, In Comprehensive Heterocyclic Chemistry Vol. 5: Katritzky AR. Rees CW. Pergamon Press; Oxford: 1984. p.457-487

Google Scholar
9d Preston PN. Benzimidazoles and Congeneric Tricyclic Compounds, In The Chemistry of Heterocyclic Compounds Part 1, Vol. 40: Weissberger A. Taylor EC. Wiley; New York: 1981. p.6-60

Google Scholar
10a Sluiter J. Christoffers J. Synlett 2009, 63

Google Scholar
10b Czarny A. Wilson WD. Boykin DW. J. Heterocycl. Chem. 1996, 33: 1393

Google Scholar
10c Tidwell RR. Geratz JD. Dann O. Volz G. Zeh D. Loewe H. J. Med. Chem. 1978, 21: 613

Google Scholar
10d Fairley TA. Tidwell RR. Donkor I. Naiman NA. Ohemeng KA. Lombardy RJ. Bentley JA. Cory M. J. Med. Chem. 1993, 36: 1746

Google Scholar
10e Treu M. Karner T. Kousek R. Berger H. Mayer M. McConnell DB. Stadler A. J. Comb. Chem. 2008, 10: 863

Google Scholar
11a Murai K. Takaichi N. Takahara Y. Fukushima S. Fujioka H. Synthesis 2010, 520

Google Scholar
11b Beaulieu PL. Haché B. von Moos E. Synthesis 2003, 1683 ; and references cited therein

Google Scholar
11c Eynde JJV. Delfosse F. Lor P. Van Haverbeke Y. Tetrahedron 1995, 51: 5813

Google Scholar
11d Du L. Wang Y. Synthesis 2007, 675

Google Scholar
12 Yamamoto Y. Mizuno H. Tsuritani T. Mase T. J. Org. Chem. 2009, 74: 1394

Google Scholar
13a Evindar G. Batey RA. Org. Lett. 2003, 5: 133

Google Scholar
13b Yang D. Fu H. Hu L. Jiang Y. Zhao Y. J. Org. Chem. 2008, 73: 7841

Google Scholar
13c Zou B. Yuan Q. Ma D. Angew. Chem. Int. Ed. 2007, 46: 2598

Google Scholar
13d Murru S. Patel BK. Le Bras J. Muzart J. J. Org. Chem. 2009, 74: 2217

Google Scholar
13e Brian CT. Steer JT. J. Org. Chem. 2003, 68: 6814

Google Scholar
13f She J. Jiang Z. Wang Y. Synlett 2009, 2023

Google Scholar
13g Zheng N. Anderson KW. Huang X. Nguyen HN. Buchwald SL. Angew. Chem. Int. Ed. 2007, 46: 7509

Google Scholar
13h Brasche G. Buchwald SL. Angew. Chem. Int. Ed. 2008, 47: 1932

Google Scholar
13i Brian CT. Brunton SA. Tetrahedron Lett. 2002, 43: 1893

Google Scholar
14a Pelter A. Levitt TE. Nelson P. Tetrahedron 1970, 26: 1545

Google Scholar
14b Collum DB. Chen S. Ganem B. J. Org. Chem. 1978, 43: 4393

Google Scholar
14c Ishihara K. Ohara S. Yamamoto H.
J. Org. Chem. 1996, 61: 4196

Google Scholar
14d Huang Z. Reilly JE. Buckle RN. Synlett 2007, 1026

Google Scholar
15a Ramsden CA. Rose HL. J. Chem. Soc., Perkin Trans. 1 1997, 2319

Google Scholar
15b Nasal A. Kaliszan R. Kuzmierkiewicz W. QSAR 1987, 6: 22

Google Scholar
15c Blacker AJ. Farah MM. Hall MI. Marsden MP. Saidi O. Williams JM. Org. Lett. 2009, 11: 2039

Google Scholar
15d Moorthy JA. Neogi I. Tetrahedron Lett. 2011, 52: 3868

Google Scholar
15e Trivedi R. De S K. Gibbs RA. J. Mol. Catal. A: Chem. 2006, 245: 8

Google Scholar
16a Roeder CJ. Day AR. J. Org. Chem. 1941, 6: 25

Google Scholar
16b Morgan KJ. Turner AM. Tetrahedron 1969, 25: 915

Google Scholar
16c Maras N. Kocevar M. Helv. Chim. Acta 2011, 94: 1860

Google Scholar

17

General Procedure for the Formation of Benzimidazoles
To a carboxylic acid (2 mmol) in toluene (10 mL) in an ice-water bath was added dropwise a solution of borane-THF (1 M, 0.70 mmol) in THF. The mixture was stirred at r.t. for 30 min. Benzene-1,2-diamine (0.66 mmol) was added, and the mixture was heated at reflux with stirring for 12 h. After cooling, the mixture was concentrated in vacuo, and the residue was purified by flash chromatography. The physical data of the products in Table [¹] , entries 1-11, 15, and 16 are consistent with those of reported literatures,^{¹0e,¹¹c,d,¹5} or those of authentic samples. The new compound characterizations are provided below.
tert -Butyl 2-(5-Methyl-1 H -benzo[ d ]imidazol-2-yl)-ethylcarbamate (Table 1, Entry 12)
^¹H NMR (300 MHz, CDCl₃): δ = 7.43 (d, J = 8.1 Hz, 1 H), 7.32 (s, 1 H), 7.04 (d, J = 8.1 Hz, 1 H), 5.40 (br, 1 H), 3.68-3.61 (m, 2 H), 3.12-3.18 (m, 2 H), 2.45 (s, 3 H), 1.40 (s, 9 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 156.7, 152.2, 132.0, 123.7, 114.3, 114.0, 79.9, 38.4, 30.2, 28.4, 21.6. ESI-HRMS: m/z calcd for C₁₅H₂₁N₃O₂ + H⁺: 276.1712; found 2761723. tert -Butyl 4-[(5-Chloro-1 H -benzo[ d ]imidazol-2-yl)-methyl]piperidine-1-carboxylate (Table 1, Entry 13) ^¹H NMR (500 MHz, CD₃OD): δ = 7.53 (d, J = 1.9 Hz, 1 H), 7.47 (d, J = 8.7 Hz, 1 H), 7.20 (dd, J = 1.5, 8.6 Hz, 1 H), 4.15 (d, J = 13.2 Hz, 2 H), 2.83 (d, J = 7.3 Hz, 2 H), 2.76 (br, 2 H), 2.10-2.02 (m, 1 H), 1.66 (d, J = 12.2 Hz, 2 H), 1.44 (s, 9 H), 1.36-1.28 (m, 2 H). ^¹³C NMR (125 MHz, CD₃OD): δ = 156.6, 156.5, 140.4, 137.8, 129.0, 123.8, 116.3, 115.4, 81.0, 44.6, 37.0, 36.4, 33.0, 28.7. ESI-HRMS: m/z calcd for C₁₈H₂₄ClN₃O₂ + H⁺: 350.1635; found: 350.1642.
5-Bromo-2-(thiophen-2-ylmethyl)-1 H -benzo[ d ]-imidazole (Table 1, Entry 14)
^¹H NMR (500 MHz, CD₃OD): δ = 7.72 (d, J = 1.5 Hz, 1 H), 7.47 (d, J = 8.5 Hz, 1 H), 7.41 (dd, J = 1.5, 8.5 Hz, 1 H), 7.32 (dd, J = 1.5, 5.5 Hz, 1 H), 7.04-7.03 (m, 1 H), 6.99 (dd, J = 3.5, 5.0 Hz, 1 H), 4.52 (s, 2 H). ^¹³C NMR (125 MHz, CD₃OD): δ = 155.8, 141.1, 139.4, 138.4, 128.1, 127.6, 126.6, 126.1, 118.7, 117.0, 116.3, 30.3. ESI-HRMS: m/z calcd for C₁₂H₉BrN₂S + H⁺: 292.9748; found: 292.9768.